Current Ratio of Taysha Gene Therapies, Inc. from 30 Jun 2021 to 31 Dec 2025
- Taxonomy & unit
- ratio: x
- Description
- The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
- Summary
-
Taysha Gene Therapies, Inc. quarterly Current Ratio in x history and change rate from 30 Jun 2021 to 31 Dec 2025.
- Taysha Gene Therapies, Inc. Current Ratio for the quarter ending 31 Dec 2025 was 10.3x, a 116% increase year-over-year.
Current Ratio, Quarterly (x)
Current Ratio, YoY Quarterly Change (%)
Taysha Gene Therapies, Inc. Quarterly Current Ratio (x)
| Period | Value | YoY Chg | Change % | Date |
|---|---|---|---|---|
| Q4 2025 | 10.3x | +5.52x | +116% | 31 Dec 2025 |
| Q3 2025 | 8.55x | +4.09x | +91% | 30 Sep 2025 |
| Q2 2025 | 7.16x | +4.98x | +229% | 30 Jun 2025 |
| Q1 2025 | 5.37x | +3.72x | +225% | 31 Mar 2025 |
| Q4 2024 | 4.77x | +3.38x | +243% | 31 Dec 2024 |
| Q3 2024 | 4.47x | +3.33x | +294% | 30 Sep 2024 |
| Q2 2024 | 2.17x | +0.85x | +64% | 30 Jun 2024 |
| Q1 2024 | 1.65x | +0.16x | +11% | 31 Mar 2024 |
| Q4 2023 | 1.39x | -0.33x | -19% | 31 Dec 2023 |
| Q3 2023 | 1.13x | -1.06x | -48% | 30 Sep 2023 |
| Q2 2023 | 1.32x | -1.58x | -54% | 30 Jun 2023 |
| Q1 2023 | 1.49x | -2.41x | -62% | 31 Mar 2023 |
| Q4 2022 | 1.72x | -3.92x | -69% | 31 Dec 2022 |
| Q3 2022 | 2.19x | -7.04x | -76% | 30 Sep 2022 |
| Q2 2022 | 2.9x | -11.99x | -81% | 30 Jun 2022 |
| Q1 2022 | 3.9x | 31 Mar 2022 | ||
| Q4 2021 | 5.65x | 31 Dec 2021 | ||
| Q3 2021 | 9.23x | 30 Sep 2021 | ||
| Q2 2021 | 14.89x | 30 Jun 2021 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.